Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJH5L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $56,279
Award facts
- Contract value 100% obligated
- $56,278.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $56,278.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 0.75 mL pens of Wegovy 2.4 mg, with an ultimate completion date of January 14, 2026. This award was not set aside and was competitively awarded to the pharmaceutical distributor, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract valued at up to $999.99 million through December 2031 with DLA Troop Support Medical for comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen's Indefinite Delivery Contract serves as a flexible vehicle enabling the company to supply a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military treatment facilities and veteran healthcare programs. Wegovy (semaglutide), a GLP-1 receptor agonist used for weight management, represents one of many therapeutic categories the company delivers under its federal contracts. This delivery order fulfills a specific requirement for the drug within the Defense Health Agency's pharmaceutical supply chain, demonstrating the vendor's continued role as a critical supplier of essential medical commodities to the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26FJH5L?
SPE2DR26FJH5L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FJH5L worth?
The government has obligated $56,279 on SPE2DR26FJH5L.
Is contract SPE2DR26FJH5L an order under another contract?
Yes. SPE2DR26FJH5L is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH5L competed?
The extent of competition for SPE2DR26FJH5L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award